Table 3 The positive rate of autoantibodies between the LMV group and the non-LMV group (%)
Autoantibodies | LMV group (n1 = 11) | Non-LMV group (n0 = 44) | \({\chi }_{{\text{C}}}^{2}\) | P |
|---|---|---|---|---|
dsDNA | 8 (72.7) | 31 (70.5) | 0.050 | 0.824 |
SSA | 7 (63.6) | 17 (38.6) | 1.3355 | 0.248 |
RO-52 | 6 (54.5) | 13 (29.5) | 1.452 | 0.228 |
Nucleosome | 3 (27.3) | 23 (52.3) | 1.138 | 0.252 |
SSB | 2 (18.2) | 5 (11.4) | 0.010 | 0.919 |
Ribosomal | 2 (18.2) | 19 (43.2) | 1.391 | 0.238 |
Sm | 2 (18.2) | 16 (36.4) | 0.625 | 0.429 |
RNP | 2 (18.2) | 18 (40.9) | 1.105 | 0.293 |
Histone | 1 (9.1) | 18 (40.9) | 2.659 | 0.103 |
Mitochondrial | 1 (9.1) | 2 (4.5) | 2.207 | 1.137 |
ANCA | 0 (0.0) | 2 (5.1)a | ―b | 1.000 |
ACL-IgG | 2 (18.2) | 7 (15.9) | 0.075 | 0.785 |
ACL-IgM | 1 (9.1) | 6 (13.6) | 0.010 | 0.919 |
β2GPI | 1 (9.1) | 12 (27.3) | 0.762 | 0.383 |